WuXi AppTec Co. posted better-than-expected third-quarter revenue despite concerns over a US bill seeking to block the ...

SouthernSun Asset Management, LLC, an investment management firm, released its “SouthernSun Small Cap Strategy” third quarter ...

William Blair analyst Sami Corwin has maintained their bullish stance on TNYA stock, giving a Buy rating yesterday. Sami Corwin has given his ...

The company's business still has some strengths ... especially within its BetterHelp therapy segment. The company engaged in aggressive marketing efforts that did not yield the expected results ...

U.S. drugmaker AbbVie said on Monday it will buy Aliada Therapeutics for $1.4 billion in cash, betting on an experimental ...

Compass Pathways is advancing pivotal trials to test psilocybin's impact on treatment-resistant depression. See why I rate ...

Analyst Michael Petusky of Barrington maintained a Buy rating on US Physical Therapy (USPH – Research Report), retaining the price target ...

Nkarta faces competition from FATE's FT522, a CAR-NK cell therapy that might be used with reduced or no conditioning ...

These preclinical findings could lead ... Single-Dose Gene Therapy Is Potentially Life-Changing for Adults With Hemophilia B Sep. 25, 2024 — Adults with hemophilia B saw their number of bleeding ...

Autolus Therapeutics’ (NASDAQ:AUTL) obe-cel has the potential to become a best-in-class cell therapy for the treatment of cancers. Industry analysts have a consensus Buy rating on the stock ...

Q3 2024 Earnings Call Nov 08, 2024, 8:30 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants. Prepar ...

This growth will likely be driven by a less restrictive monetary policy and ongoing improvements in real wages, which could boost consumption and business investment. However, in the longer term ...